A second group of breast cancer patients is characterized by an amplification of chromosome region 17q12-21, leading to the overexpression of the epidermal growth factor receptor 2, ERBB2/HER2/neu (Wolff et al. 2007). This evidence concerns the gene ERBB2 and breast carcinoma.